[1] Jin YF, Yang HY, Ji WQ, et al.  Virology, epidemiology, pathogenesis, and control of COVID-19[J]. Viruses, 2020, 12(4): 372-.   doi: 10.3390/v12040372
[2]

WHO. Coronavirus disease 2019 (COVID-19) situation report-176[EB/OL]. (2020-07-14)[2020-07-15]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200714-covid-19-sitrep-176.pdf?sfvrsn=d01ce263_2.
[3]

国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL]. (2020-03-04)[2020-07-21]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.

National Health and Health Commission of the People's Republic of China. "Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial seventh edition)"[EB/OL]. (2020-03-04)[2020-06-21]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.
[4] Yang Y, Yang MH, Shen CG, et al.  Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections[J]. medRxiv, 2020, : 2020-2022.   doi: 10.1101/2020.02.11.20021493
[5] Ai T, Yang ZL, Hou HY, et al.  Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases[J]. Radiology, 2020, 296(2): E32-E40.   doi: 10.1148/radiol.2020200642
[6] Pan YY, Guan HX, Zhou SC, et al.  Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China[J]. Eur Radiol, 2020, 30(6): 3306-3309.   doi: 10.1007/s00330-020-06731-x
[7]

Yuan M, Yin W, Tao Z, et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China[J/OL]. PLoS One, 2020,15(3): e230548[2020-07-21]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0230548. DOI: 10.1371/journal.pone.0230548.
[8] Treglia G.  Diagnostic performance of 18F-FDG PET/CT in infectious and inflammatory diseases according to published Meta-analyses[J]. Contrast Media Mol Imaging, 2019, 2019: 3018349-.   doi: 10.1155/2019/3018349
[9] Capitanio S, Nordin AJ, Noraini AR, et al.  PET/CT in nononcological lung diseases: current applications and future perspectives[J]. Eur Respir Rev, 2016, 25(141): 247-258.   doi: 10.1183/16000617.0051-2016
[10] Huang CL, Wang YM, Li XW, et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506.   doi: 10.1016/S0140-6736(20)30183-5
[11] Chung M, Bernheim A, Mei XY, et al.  CT imaging features of 2019 novel coronavirus (2019-nCoV)[J]. Radiology, 2020, 295(1): 202-207.   doi: 10.1148/radiol.2020200230
[12] Shi HS, Han XY, Jiang NC, et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study[J]. Lancet Infect Dis, 2020, 20(4): 425-434.   doi: 10.1016/S1473-3099(20)30086-4
[13] Macmahon H, Naidich DP, Goo JM, et al.  Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society 2017[J]. Radiology, 2017, 284(1): 228-243.   doi: 10.1148/radiol.2017161659
[14] Qin CX, Liu F, Yen TC, et al.  18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases[J]. Eur J Nucl Med Mol Imaging, 2020, 47(5): 1281-1286.   doi: 10.1007/s00259-020-04734-w
[15] Zhou J, Li YL, Zhang YQ, et al.  Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma[J]. Oncotarget, 2017, 8(14): 23312-23321.   doi: 10.18632/oncotarget.15577
[16] 刘宝东.  肺磨玻璃结节的诊治策略[J]. 中国肺癌杂志, 2019, 22(7): 449-456.   doi: 10.3779/j.issn.1009-3419.2019.07.07
Liu BD.  Diagnosis and treatment of pulmonary ground-glass nodules[J]. Chin J Lung Cancer, 2019, 22(7): 449-456.   doi: 10.3779/j.issn.1009-3419.2019.07.07
[17]

Zou SJ, Zhu XH. FDG PET/CT of COVID-19[J/OL]. Radiology, 2020, 296(2): E118[2020-07-21]. https://pubs.rsna.org/doi/10.1148/radiol.2020200770. DOI:10.1148/radiol.2020200770.
[18] Liu CB, Zhou J, Xia L, et al.  18F-FDG PET/CT and serial chest CT findings in a COVID-19 patient with dynamic clinical characteristics in different period[J]. Clin Nucl Med, 2020, 45(6): 495-496.   doi: 10.1097/RLU.0000000000003068
[19] Zhou X, Li Y, Li TS, et al.  Follow-up of asymptomatic patients with SARS-CoV-2 infection[J]. Clin Microbiol Infect, 2020, 26(7): 957-959.   doi: 10.1016/j.cmi.2020.03.024
[20] Fung SY, Yuen KS, Ye ZW, et al.  A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses[J]. Emerg Microbes Infect, 2020, 9(1): 558-570.   doi: 10.1080/22221751.2020.1736644
[21] Dai MY, Liu DB, Liu M, et al.  Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak[J]. Cancer Discov, 2020, 10(6): 783-791.   doi: 10.1158/2159-8290.CD-20-0422
[22] Albano D, Bertagna F, Bertoli M, et al.  Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region[J]. J Nucl Med, 2020, 61(5): 632-636.   doi: 10.2967/jnumed.120.246256
[23] Polverari G, Arena V, Ceci F, et al.  18F-Fluorodeoxyglucose uptake in patient with asymptomatic severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) referred to positron emission tomography/computed tomography for NSCLC restaging[J]. J Thorac Oncol, 2020, 15(6): 1078-1080.   doi: 10.1016/j.jtho.2020.03.022
[24] Setti L, Kirienko M, Dalto SC, et al.  FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients[J]. Eur J Nucl Med Mol Imaging, 2020, 47(7): 1649-1656.   doi: 10.1007/s00259-020-04819-6
[25] Czernin J, Fanti S, Meyer PT, et al.  Nuclear medicine operations in the times of COVID-19: strategies, precautions, and experiences[J]. J Nucl Med, 2020, 61(5): 626-629.   doi: 10.2967/jnumed.120.245738
[26] Krebs S, Petkovska I, Ho AL, et al.  Laboratory-proven asymptomatic SARS-CoV-2 (COVID-19) infection on 18F-FDG PET/CT[J]. Clin Nucl Med, 2020, 45(8): 654-655.   doi: 10.1097/RLU.0000000000003141
[27] Martineau P, Kidane B.  FDG PET/CT findings in an asymptomatic case of confirmed COVID-19[J]. Clin Nucl Med, 2020, 45(8): 647-648.   doi: 10.1097/RLU.0000000000003145
[28] Amini H, Divband G, Montahaei Z, et al.  A case of COVID-19 lung infection first detected by 18F-FDG PET/CT[J]. Eur J Nucl Med Mol Imaging, 2020, 47(7): 1771-1772.   doi: 10.1007/s00259-020-04821-y
[29] Chefer S, Thomasson D, Seidel J, et al.  Modeling 18F-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to middle east respiratory syndrome-coronavirus aerosol challenge[J]. EJNMMI Res, 2015, 5(1): 65-.   doi: 10.1186/s13550-015-0143-x
[30] Dyall J, Johnson RF, Chen D, et al.  Evaluation of monkeypox disease progression by molecular imaging[J]. J Infect Dis, 2011, 204(12): 1902-1911.   doi: 10.1093/infdis/jir663
[31] Zhu JY, Zhong ZM, Li HY, et al.  CT imaging features of 4121 patients with COVID-19: a meta-analysis[J]. J Med Virol, 2020, 92(7): 891-902.   doi: 10.1002/jmv.25910
[32] Li XC, Wang Y, Bai Y, et al.  PET/MR and PET/CT in a severe COVID-19 patient[J]. Eur J Nucl Med Mol Imaging, 2020, 47(10): 2478-2479.   doi: 10.1007/s00259-020-04887-8
[33] Lan J, Ge JW, Yu JF, et al.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor[J]. Nature, 2020, 581(7807): 215-220.   doi: 10.1038/s41586-020-2180-5
[34] Hamming I, Timens W, Bulthuis MLC, et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis[J]. J Pathol, 2004, 203(2): 631-637.   doi: 10.1002/path.1570
[35] Mao L, Jin HJ, Wang MD, et al.  Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China[J]. JAMA Neurol, 2020, 77(6): 683-690.   doi: 10.1001/jamaneurol.2020.1127
[36] Karimi-Galougahi M, Yousefi-Koma A, Bakhshayeshkaram M, et al.  18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19[J]. Acad Radiol, 2020, 27(7): 1042-1043.   doi: 10.1016/j.acra.2020.04.030
[37]

Micarelli A, Pagani M, Chiaravalloti A, et al. Cortical metabolic arrangement during olfactory processing: proposal for a 18F FDG PET/CT methodological approach[J/OL]. Medicine (Baltimore), 2014, 93(19): e103[2020-07-21]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616321. DOI: 10.1097/MD.0000000000000103.
[38] Guan WJ, Ni ZY, Hu Y, et al.  Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020, 382(18): 1708-1720.   doi: 10.1056/NEJMoa2002032
[39] Zhang W, Du RH, Li B, et al.  Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes[J]. Emerg Microbes Infect, 2020, 9(1): 386-389.   doi: 10.1080/22221751.2020.1729071
[40]

Doroudinia A, Tavakoli M. A case of coronavirus infection incidentally found on FDG PET/CT scan[J/OL]. Clin Nucl Med, 2020, 45(7): e303−e304[2020-07-21]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268833. DOI: 10.1097/RLU.0000000000003084.
[41] Bradley BT, Maioli H, Johnston R, et al.  Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series[J]. Lancet, 2020, 396(10247): 320-332.   doi: 10.1016/S0140-6736(20)31305-2
[42] Sekulic M, Harper H, Nezami BG, et al.  Molecular detection of SARS-CoV-2 infection in FFPE samples and histopathologic findings in fatal SARS-CoV-2 cases[J]. Am J Clin Pathol, 2020, 154(2): 190-200.   doi: 10.1093/ajcp/aqaa091